Expand / Collapse search
Watch TV
☰

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2025 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

healthstream inc. - HSTM

HSTM

Close Chg Chg %
31.89 -0.66 -2.07%

Open Market

31.23

-0.66 (2.07%)

Volume: 24.89K

Last Updated:

Apr 4, 2025, 10:34 AM EDT

Trade Now

Company Overview: healthstream inc. - HSTM

HSTM Key Data

Open

$31.14

 Day Range

31.14 - 31.51

52 Week Range

23.92 - 34.24

 Market Cap

$987.59M

Shares Outstanding

30.43M

 Public Float

24.10M

Beta

0.42

 Rev. Per Employee

N/A

P/E Ratio

49.54

 EPS

$0.66

Yield

35.44%

 Dividend

$0.03

EX-DIVIDEND DATE

Mar 10, 2025

 SHORT INTEREST

N/A

AVERAGE VOLUME

184.45K

  

HSTM Performance

1 Week
 
 -0.44%
 
1 Month
 
 -2.86%
 
3 Months
 
 -0.47%
 
1 Year
 
 26.80%
 
5 Years
 
 33.71%
 

HSTM Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 5
Full Ratings ➔

About healthstream inc. - HSTM

HealthStream, Inc. engages in the provision of services to healthcare organizations. It develops healthcare technology platforms for workforce solutions. The firm’s workforce solutions include learning management, nurse & staff scheduling, clinical education, credentialing, privileging, provider enrollment, performance assessment, and managing simulation-based education programs. The company was founded by Robert A. Frist, Jr. and Jeffery L. McLaren in 1990 and is headquartered in Nashville, TN.

HSTM At a Glance

HealthStream, Inc.
500 11th Avenue North
Nashville, Tennessee 37203-2015
Phone 1-615-301-3100 Revenue 291.65M
Industry Packaged Software Net Income 20.01M
Sector Technology Services 2024 Sales Growth 4.509%
Fiscal Year-end 12 / 2025 Employees 1,093
View SEC Filings

HSTM Valuation

P/E Current 49.542
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 48.55
Price to Sales Ratio 3.33
Price to Book Ratio 2.693
Price to Cash Flow Ratio 16.845
Enterprise Value to EBITDA 14.301
Enterprise Value to Sales 3.066
Total Debt to Enterprise Value 0.023

HSTM Efficiency

Revenue/Employee 266,830.741
Income Per Employee 18,304.666
Receivables Turnover 8.257
Total Asset Turnover 0.57

HSTM Liquidity

Current Ratio 1.324
Quick Ratio 1.324
Cash Ratio 0.84

HSTM Profitability

Gross Margin 52.278
Operating Margin 7.299
Pretax Margin 8.504
Net Margin 6.86
Return on Assets 3.913
Return on Equity 5.715
Return on Total Capital 5.272
Return on Invested Capital 5.424

HSTM Capital Structure

Total Debt to Total Equity 5.612
Total Debt to Total Capital 5.314
Total Debt to Total Assets 3.858
Long-Term Debt to Equity 4.833
Long-Term Debt to Total Capital 4.576
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Healthstream Inc. - HSTM

Collapse All in section
All values USD millions. 2021 2022 2023 2024 5-year trend
Sales/Revenue
256.71M 266.83M 279.06M 291.65M
Sales Growth
+4.85% +3.94% +4.59% +4.51%
Cost of Goods Sold (COGS) incl D&A
127.85M 129.09M 136.10M 139.18M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
36.81M 37.95M 41.08M 41.24M
Depreciation
6.30M 4.50M 4.20M 3.80M
Amortization of Intangibles
30.51M 33.45M 36.88M 37.44M
COGS Growth
+6.97% +0.97% +5.43% +2.26%
Gross Income
128.87M 137.74M 142.97M 152.47M
Gross Income Growth
+2.84% +6.88% +3.80% +6.65%
Gross Profit Margin
+50.20% +51.62% +51.23% +52.28%
2021 2022 2023 2024 5-year trend
SG&A Expense
120.81M 125.29M 126.95M 131.18M
Research & Development
41.66M 44.28M 45.54M 48.89M
Other SG&A
79.15M 81.01M 81.41M 82.29M
SGA Growth
+10.34% +3.71% +1.32% +3.33%
Other Operating Expense
- - - -
-
Unusual Expense
- - 183.00K (2.85M)
-
EBIT after Unusual Expense
7.87M 15.30M 16.02M 21.29M
Non Operating Income/Expense
(106.00K) 287.00K 2.49M 3.52M
Non-Operating Interest Income
- - - 3.83M
-
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
- - - -
-
Interest Expense Growth
- - - -
-
Gross Interest Expense
- - - -
-
Interest Capitalized
- - - -
-
Pretax Income
7.77M 15.59M 18.51M 24.80M
Pretax Income Growth
-56.43% +100.68% +18.77% +33.99%
Pretax Margin
+3.03% +5.84% +6.63% +8.50%
Income Tax
1.92M 3.49M 3.30M 4.80M
Income Tax - Current - Domestic
411.00K 2.90M 5.01M 5.90M
Income Tax - Current - Foreign
(29.00K) (110.00K) 15.00K 14.00K
Income Tax - Deferred - Domestic
1.63M 734.00K (1.71M) (1.05M)
Income Tax - Deferred - Foreign
(86.00K) (25.00K) (18.00K) (64.00K)
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
5.84M 12.09M 15.21M 20.01M
Minority Interest Expense
- - - -
-
Net Income
5.84M 12.09M 15.21M 20.01M
Net Income Growth
-58.52% +106.86% +25.82% +31.51%
Net Margin Growth
+2.28% +4.53% +5.45% +6.86%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
5.84M 12.09M 15.21M 20.01M
Preferred Dividends
- - - -
-
Net Income Available to Common
5.84M 12.09M 15.21M 20.01M
EPS (Basic)
0.1854 0.3945 0.4976 0.6584
EPS (Basic) Growth
-57.95% +112.78% +26.13% +32.32%
Basic Shares Outstanding
31.53M 30.65M 30.57M 30.39M
EPS (Diluted)
0.1849 0.3936 0.496 0.655
EPS (Diluted) Growth
-58.02% +112.87% +26.02% +32.06%
Diluted Shares Outstanding
31.62M 30.72M 30.67M 30.54M
EBITDA
44.87M 50.39M 57.09M 62.53M
EBITDA Growth
-2.48% +12.32% +13.30% +9.52%
EBITDA Margin
+17.48% +18.89% +20.46% +21.44%

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 32.50
Number of Ratings 5 Current Quarters Estimate 0.152
FY Report Date 06 / 2025 Current Year's Estimate 0.664
Last Quarter’s Earnings 0.15 Median PE on CY Estimate N/A
Year Ago Earnings 0.66 Next Fiscal Year Estimate 0.687
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 5 5 5 3
Mean Estimate 0.15 0.17 0.66 0.69
High Estimates 0.16 0.19 0.70 0.71
Low Estimate 0.15 0.16 0.64 0.66
Coefficient of Variance 2.94 6.55 3.47 3.66

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 2 2 2
OVERWEIGHT 0 0 0
HOLD 3 3 4
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Overweight Overweight Overweight

Insider Actions for Healthstream Inc. - HSTM

Date Name Shares Transaction Value
Mar 24, 2025 Trisha L. Coady Executive Vice President 2,376 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 24, 2025 Robert A. Frist CEO and Chairman; Director 2,376 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 24, 2025 Michael M. Collier Executive Vice President 2,376 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 24, 2025 Scott Fenstermacher Senior Vice President 1,426 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 24, 2025 Jeffrey D. Cunningham Chief Technology Officer 1,901 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 24, 2025 Michael Scott McQuigg Senior Vice President 1,901 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 24, 2025 Scott A. Roberts CFO and SVP 1,901 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 24, 2025 Kevin P. O'Hara Executive Vice President 2,376 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 3, 2025 Scott Fenstermacher Senior Vice President 12,327 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $33.15 per share 408,640.05
Feb 28, 2025 Michael Scott McQuigg Senior Vice President 6,500 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Feb 28, 2025 Michael Scott McQuigg Senior Vice President 23,565 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Feb 28, 2025 Michael Scott McQuigg Senior Vice President 3,606 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 28, 2025 Kevin P. O'Hara Executive Vice President 5,490 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Feb 28, 2025 Kevin P. O'Hara Executive Vice President 6,500 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Feb 28, 2025 Kevin P. O'Hara Executive Vice President 14,843 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Feb 28, 2025 Michael J. Sousa Executive Vice President 62,015 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $32.37 per share 2,007,425.55
Feb 28, 2025 Michael M. Collier Executive Vice President 44,453 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Feb 28, 2025 Michael M. Collier Executive Vice President 11,700 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Feb 28, 2025 Jeffrey D. Cunningham Chief Technology Officer 27,987 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Feb 28, 2025 Michael J. Sousa Executive Vice President 39,000 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00

Healthstream Inc. in the News